Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

999 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Clinical efficacy of iodine complex in SARS-CoV-2-infected patients with mild to moderate symptoms: study protocol for a randomized controlled trial.
Ashraf S, Ashraf S, Ashraf M, Farooq I, Akmal R, Imran MA, Kalsoom L, Ashraf S, Rafique S, Ghufran M, Akram MK, Sohaib-Ur-Rehman, Nadeem MF, Matti N, Siddiqui UN, Humayun A, Saboor QA, Ahmad A, Ashraf M, Izhar M; DOCTORS LOUNGE consortium. Ashraf S, et al. Among authors: ashraf m. Trials. 2022 Jan 19;23(1):58. doi: 10.1186/s13063-021-05848-8. Trials. 2022. PMID: 35045888 Free PMC article.
Zoonotic and reverse zoonotic events of SARS-CoV-2 and their impact on global health.
Munir K, Ashraf S, Munir I, Khalid H, Muneer MA, Mukhtar N, Amin S, Ashraf S, Imran MA, Chaudhry U, Zaheer MU, Arshad M, Munir R, Ahmad A, Zhao X. Munir K, et al. Among authors: ashraf s. Emerg Microbes Infect. 2020 Dec;9(1):2222-2235. doi: 10.1080/22221751.2020.1827984. Emerg Microbes Infect. 2020. PMID: 32967592 Free PMC article. Review.
A quadruple blinded placebo controlled randomised trial to evaluate the effectiveness of an Iodine complex for patients with mild to moderate COVID-19 in Pakistan (I-COVID-PK): A structured summary of a study protocol for a randomised controlled trial.
Ashraf S, Ashraf S, Ashraf M, Imran MA, Kalsoom L, Siddiqui UN, Farooq I, Ghufran M, Khokhar RA, Akram MK, Shahid I, Sohaib Ur Rehman M, Akmal R, Tahir A, Zahid A, Ashraf S, Rafique S, Matti N, Nadeem MF, Humayun A, Malik A, Saboor QA, Ahmad A, Ashraf M, Izhar M. Ashraf S, et al. Among authors: ashraf m. Trials. 2021 Feb 10;22(1):127. doi: 10.1186/s13063-021-05081-3. Trials. 2021. PMID: 33568226 Free PMC article.
COVID-19: A Potential Trigger for Thyroid Dysfunction.
Ashraf S, Imran MA, Ashraf S, Hafsa HT, Khalid S, Akram MK, Ghufran M, Cheema KK, Ahmad A, Izhar M. Ashraf S, et al. Am J Med Sci. 2021 Sep;362(3):303-307. doi: 10.1016/j.amjms.2021.05.013. Epub 2021 May 21. Am J Med Sci. 2021. PMID: 34023311 Free PMC article.
An in vitro antiviral activity of iodine complexes against SARS-CoV-2.
Altaf I, Nadeem MF, Hussain N, Nawaz M, Raza S, Shabbir MAB, Ashraf MA, Ali MA, Hassan S, Aziz MW, Matti N, Ashraf M, Ulla I, Fazal S, Rafique S, Mehmood A, Sardar N, Khan MT, Atique HMM, Ashraf S, Tahir Z, Mukhtar N, Yaqub T. Altaf I, et al. Among authors: ashraf m, ashraf ma, ashraf s. Arch Microbiol. 2021 Sep;203(7):4743-4749. doi: 10.1007/s00203-021-02430-3. Epub 2021 Jun 16. Arch Microbiol. 2021. PMID: 34136927 Free PMC article.
Anti-COVID property of subcutaneous ivermectin in synergy with zinc among midlife moderately symptomatic patients: a structured summary of a study protocol for a randomised controlled trial.
Ashraf S, Ashraf S, Farooq I, Ashraf S, Ashraf M, Imran MA, Kalsoom L, Akmal R, Ghufran M, Rafique S, Akram MK, Habib Z, Siddiqui UN, Ahmad A, Arshad S, Virk MAR, Gul M, Awais AB, Hassan M, Sherazi SSH, Safdar Z, Munir I, Khalid H, Munir K, Majeed N, Alahmadi YM, Humayun A, Saboor QA, Ahmad A, Ashraf M, Izhar M; DOCTORS LOUNGE Consortium. Ashraf S, et al. Among authors: ashraf m. Trials. 2021 Sep 6;22(1):591. doi: 10.1186/s13063-021-05487-z. Trials. 2021. PMID: 34488858 Free PMC article.
Knowledge, attitude, and practice of clinicians about antimicrobial stewardship and resistance among hospitals of Pakistan: a multicenter cross-sectional study.
Ashraf S, Ashraf S, Ashraf M, Imran MA, Choudhary ZA, Hafsa HT, Awais AB, Kalsoom L, Farooq I, Habib Z, Ashraf S, Iqbal QUA, Ghufran M, Sherazi SSH, Akram MK, Akmal R, Rafique S, Nawaz K, Safdar Z, Siddique UN, Hassan M, Arshad S, Virk AR, Ashraf M, Saboor QA, Humayun A, Izhar M. Ashraf S, et al. Among authors: ashraf m. Environ Sci Pollut Res Int. 2022 Feb;29(6):8382-8392. doi: 10.1007/s11356-021-16178-2. Epub 2021 Sep 6. Environ Sci Pollut Res Int. 2022. PMID: 34490566 Free PMC article.
Prophylactic potential of honey and Nigella sativa L. against hospital and community-based SARS-CoV-2 spread: a structured summary of a study protocol for a randomised controlled trial.
Ashraf S, Ashraf S, Akmal R, Ashraf M, Kalsoom L, Maqsood A, Imran MA, Farooq I, Ashraf S, Siddiqui UN, Ghufran M, Akram MK, Majeed N, Rafique S, Habib Z, Shahab MS, Akmal A, Shaukat Z, Abdin ZU, Khaqan A, Arshad S, Rehman Virk MA, Gul M, Awais AB, Hassan M, Khalid N, Iqbal QUA, Ahmad T, Akram M, Muhammad A, Khalil M, Aslam A, Umer M, Sherazi SSH, Safdar Z, Ahmad S, Bilal M, Zahid MN, Koshak AE, Hilal A, Malik AA, Iqbal U, Baig AA, Alahmadi YM, Humayun A, Malik A, Ahmad A, Ashraf M, Saboor QA, Izhar M; DOCTORS LOUNGE consortium. Ashraf S, et al. Among authors: ashraf m. Trials. 2021 Sep 15;22(1):618. doi: 10.1186/s13063-021-05510-3. Trials. 2021. PMID: 34526081 Free PMC article.
Honey and Nigella sativa against COVID-19 in Pakistan (HNS-COVID-PK): A multicenter placebo-controlled randomized clinical trial.
Ashraf S, Ashraf S, Ashraf M, Imran MA, Kalsoom L, Siddiqui UN, Farooq I, Akmal R, Akram MK, Ashraf S, Ghufran M, Majeed N, Habib Z, Rafique S, -Abdin ZU, Arshad S, Shahab MS, Ahmad S, Zheng H, Mirza AR, Zulfiqar S, Anwar MI, Humayun A, Mahmud T, Saboor QA, Ahmad A, Ashraf M, Izhar M; DOCTORS LOUNGE consortium. Ashraf S, et al. Among authors: ashraf m. Phytother Res. 2023 Feb;37(2):627-644. doi: 10.1002/ptr.7640. Epub 2022 Nov 24. Phytother Res. 2023. PMID: 36420866 Clinical Trial.
Factors Responsible for Worse Outcomes in STEMI Patients With Early vs Delayed Treatment Presenting in a Tertiary Care Center in a Third World Country.
Ashraf S, Farooq U, Shahbaz A, Khalique F, Ashraf M, Akmal R, Siddal MT, Ashraf M, Ashraf S, Ashraf S, Ghufran M, Akram MK, Saboor QA. Ashraf S, et al. Among authors: ashraf m. Curr Probl Cardiol. 2024 Jan;49(1 Pt B):102049. doi: 10.1016/j.cpcardiol.2023.102049. Epub 2023 Sep 2. Curr Probl Cardiol. 2024. PMID: 37666350 Review.
999 results